The relevance of a bank with genotyped platelets donors

Barbagallo, Natália Bollini de Araújo; Costa, Thiago Henrique; Bastos, Eduardo; Aravechia, Maria Giselda; Kutner, Jose Mauro; Bonet-Bub, Carolina.
Hematol., Transfus. Cell Ther. (Impr.) ; 44(4): 465-471, Oct.-dec. 2022. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1421531

Documentos relacionados

  1. A machine-learning method for biobank-scale genetic prediction of blood group antigens.
  2. Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics.
  3. Differentiating patient characteristics between platelet refractory patients with and without antibodies to human leukocyte antigens.
  4. Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation.
  5. Severe neonatal thrombocytopenia due to anti-HPA-4b alloantibodies: Third report described in a Caucasian mother.
  6. Human platelet antigens in Burmese, Karen and north-eastern Thais.
  7. Genetic landscape of human platelet antigen variants in the Indian population analysed from 1029 whole genomes.
  8. A first WHO reference reagent for the detection of anti-human platelet antigen-15b.
  9. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
  10. HLA antibodies in fetal and neonatal alloimmune thrombocytopenia.